At what age is lymphoblastic lymphoma, a type of non-Hodgkin lymphoma (NHL), most commonly diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lymphoblastic Lymphoma: Age Distribution

Lymphoblastic lymphoma predominantly affects children and adolescents, with the majority of cases occurring in patients aged 10-30 years, and a median age at diagnosis in the teens to early twenties. 1, 2

Age-Specific Epidemiology

  • Lymphoblastic lymphoma (LBL) accounts for 25-35% of all non-Hodgkin lymphomas in children and adolescents, making it the second most common NHL subtype in this age group 3, 4

  • The disease occurs more commonly in children than in adults, with a marked male predominance 1

  • Patients typically present in their teens to twenties, with most cases diagnosed during adolescence and young adulthood 1

  • Within the adolescent and young adult (AYA) population aged 15-39 years, lymphoblastic lymphoma represents one of the most common aggressive lymphoma subtypes 2

Lineage-Specific Age Patterns

  • T-lymphoblastic lymphoma (T-LBL) comprises 70-80% of all LBL cases and shows a strong predilection for younger patients, particularly adolescent males 3, 4

  • Precursor B-lymphoblastic lymphoma (pB-LBL) accounts for 20-25% of cases and is less common overall 4

  • T-LBL patients compared to B-LBL patients tend to be younger, typically presenting in their teens with mediastinal masses 1

Clinical Context and Presentation

  • Adolescent and young adult males in their teens to twenties typically present with lymphadenopathy in cervical, supraclavicular, and axillary regions, or with an anterior mediastinal mass 1

  • The mediastinal mass is frequently bulky and associated with pleural effusions, superior vena cava syndrome, tracheal obstruction, and pericardial effusions 1

  • Most patients present with advanced disease, B symptoms, and elevated serum LDH levels 1

Important Clinical Distinction

  • Unlike acute lymphoblastic leukemia (ALL), which has a median age at diagnosis of 13-17 years and represents 75-80% of acute leukemias in children, LBL presents as a mass lesion with <25% bone marrow blasts 5, 6

  • While 80% of precursor B-cell neoplasms present as acute leukemias with bone marrow involvement, only a small proportion present as lymphoblastic lymphoma 1

Prognosis by Age

  • Event-free and overall survival for pediatric LBL patients now exceeds 80% with current ALL-type chemotherapy regimens 3, 4

  • Disease-free survival ranges from 73-90% in children compared to 45-72% in adults, demonstrating the age-dependent nature of outcomes 1

  • Outcomes for relapsed or refractory disease remain dismal across all age groups, making upfront cure critical 4

References

Research

Lymphoblastic lymphoma.

Critical reviews in oncology/hematology, 2011

Research

Lymphoma in adolescents and young adults.

Seminars in oncology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Leukemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.